亚太电子临床解决方案市场 – 行业趋势和 2030 年预测

亚太地区电子临床解决方案市场分析和规模

亚太地区电子临床解决方案市场本质上是分散的，因为它由许多全球参与者组成，例如 Oracle、IQVIA Inc.、Dassault Systemes 和 Clario 等。这些公司的存在为整个地区的系统服务和软件提供了具有竞争力的价格。由于这些参与者在区域和国际层面的存在，供应商和制造商提供具有不同规格和特点的产品，适合所有预算。电子数据采集 (EDC) 系统和基于云的解决方案的日益普及正在推动市场增长。此外，对以患者为中心的临床试验的日益关注预计将推动市场增长。

Data Bridge Market Research 分析称，亚太地区电子临床解决方案市场预计到 2030 年将达到 28.6792 亿美元，预测期内复合年增长率为 12.9%。本市场报告还深入介绍了定价分析和技术进步。

Market Definition

The goal of e-clinical solutions is to revolutionize the field of clinical research. The clinical management organization is trying to improve the effectiveness, efficiency, and accessibility of clinical research data to treat patients more quickly. The idea behind the creation of eClinical Solutions was to pinpoint the problems with clinical research data, fix them, and offer creative solutions to make clinical trial data useful and simple to obtain, as well as to facilitate the standardization, reporting, and operation of the clinical research domain. The rising adoption and growing focus towards the e clinical solutions and software are expected to drive market growth.

 The e-clinical solutions, such as electronic data capture (EDC), electronic patient-reported outcomes (ePRO), clinical trial management systems (CTMS), and electronic trial master file (eTMF) systems, are software programs used in clinical research to manage clinical data. However, strict regulations and standards for the approval of clinical trial studies and product approvals are expected to restrain market growth.

Asia-Pacific e-Clinical Solutions Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

Increasing R&D activities and corresponding expenditure

Research & development is crucial in all industries, including life science and healthcare. The life science industry carries out extensive research and development to generate revenue and often brings results that embrace saving or enhancing a patient's life. Drug development requires going through clinical trials to check clinical data analysis and review its study and new data insights.

The e-clinical solutions are used for comprehensive data review, automating the data transformation process, and analytics to accelerate timelines. Pharmaceutical and biopharmaceutical companies conduct many clinical trials to complete successful drug or biologic development. Pharmaceutical and biopharmaceutical companies have increased their focus on research and development, raising the demand for e-clinical solutions.

Improved healthcare infrastructure and establishment of advanced laboratories

Infrastructure is a key pillar supporting the fundamental aim of promoting improved standards of care and well-being for all patients, together with a good healthcare system experience. In parallel, the healthcare system and staff must support effective health promotion, prevention, and self-care of the whole population.

Infrastructure must integrate the hospital, as the acute and in-patient care center, into the broader healthcare system. It should facilitate the seven domains of quality patient experience, effectiveness, efficiency, timeliness, safety, equity, and sustainability. Infrastructure includes the built environment and supporting elements such as equipment, access, information technology (IT), systems and processes, sustainability initiatives, and staff. This improved healthcare infrastructure and staff more opportunities for e-clinical solutions to grow and give better results.

OPPORTUNITY

 Increasing investments by various governments in clinical trials

Clinical trial funding comes from various sources, including the government, commercial investors, nonprofit organizations, academic institutions, and other research organizations. Historically, the National Institutes of Health (NIH) has made the biggest government investments in fundamental drug development research. The defense advanced research agency (DARPA) has also contributed to the discovery stage by accepting a few relatively high-risk biologic initiatives. State governments are also increasingly taking the lead in this area, partly due to the public's frustration with the lengthy discovery process. Thus, government initiatives and investments toward discovering new drugs with trial studies are expected to create an opportunity for market growth.

RESTRAINT / CHALLENGE

Data Safety and Privacy issues

Information systems are heavily concerned with privacy and security. Access to individual health information is made possible by digitalizing healthcare services from any electronic device with an internet connection anywhere globally. Users typically are unaware of how their data is handled. Healthcare data on the cloud has caught the attention of hackers, who target systems to launch attacks and steal sensitive data in exchange for financial benefit.

Data breaches have been common since 2019, over 50 million electronic medical records have been hacked in 2021, and the number of security breaches was predicted to increase every year. The creation of inter-jurisdictional data-sharing agreements and the storage and manipulation of data holdings are significantly hampered by concerns about personal privacy and information confidentiality and the recent enactment of privacy and confidentiality legislation across the provinces and territories (exceptionally patient records). Thus, it is a restraint for the Asia-Pacific e-clinical solutions market and is expected to hamper market growth.

Post-COVID-19 Impact on the Asia-Pacific e-Clinical Solutions Market

The COVID-19 created a positive impact on the Asia-Pacific e-clinical solutions market. The lockdown restriction led to the emergence of various opportunities such as drug development, EMR and EHR application installation, and many others.

However, increasing government support and advanced and innovative techniques are expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players are expected to further fuel market growth. Also, the growth was high since the market opened after COVID-19, and it is expected that there will be considerable growth in the sector. The market players are conducting multiple activities to improve the trial study techniques. With this, the companies will bring advancement and innovation to the market.

Recent Developments

• In April 2023, the Medidata subsidiary of Dassault Systèmes announced Lambda Therapeutics is deploying Medidata's cloud-based clinical products, Rave EDC, Rave RTSM, and Rave Imaging, according to a statement from Dassault Systèmes subsidiary Medidata. Automating and optimizing data management operations and securely delivering higher-quality data for quicker insights will further improve clinical trial productivity. This has aided the business in promoting its offerings across the globe
• In March 2023, Clario has launched a cloud-based Image Viewer tool that helps the Sponsors and CROs to see the images of their clinical trials. Previously, several organizations had to participate in the image transfer procedure to see photos for a clinical trial. This complicated the already risky process and increased the possibility of delays and mistakes. This has aided the business in growing its service offering

Asia-Pacific e-Clinical Solutions Market Scope

The Asia-Pacific e-clinical solutions market is segmented into six notable segments based on product, delivery mode, clinical trial phase, organization size, user device, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Product

• Electronic Data Capture and Clinical Data Management Systems
• Clinical Trial Management Systems
• Clinical Analytics Platforms
• Care Coordination Medical Record (CCMR)
• Randomization and Trial Supply Management
• Clinical Data Integration Platforms
• Electronic Clinical Outcome Assessment Solutions
• Safety Solutions
• Electronic Trial Master File  Systems
• Regulatory Information Management Solutions
• Others

Based on product, the market is segmented into electronic data capture and clinical data management, clinical trial management systems,  clinical analytics platforms, care coordination medical record (CCMR), randomization and trial supply management, clinical data integration platforms, electronic clinical outcome assessment solutions, safety solutions, electronic trial master file systems, regulatory information management solutions, and others.

Delivery Mode

• Web-Hosted (On-Demand) Solutions
• Licensed Enterprise (On-Premises) Solutions
• Cloud-based (SAAS) Solutions

Based on delivery mode, the market is segmented into web-hosted (on-demand) solutions, licensed enterprise (on-premises) solutions, and cloud-based (SAAS) solutions.

Clinical Trial Phase

• Phase I
• Phase II
• Phase III
• Phase IV

Based on clinical trial phase, the market is segmented into Phase I, Phase II, Phase III, and Phase IV.

Organization Size

• Small & Medium
• Large

Based on organization size, the market is segmented into small & medium and large.

User Device

• Desktop
• Tablet
• Handheld PDA Device
• Smart Phone
• Others

Based on user device, the market is segmented into desktop, tablet, handheld PDA device, smart phone, and others.

End User

• Pharmaceutical and Biopharmaceutical companies
• Contract Research Organizations
• Consulting Service Companies
• Medical Device Manufacturers
• Hospitals
• Academic Research Institutes

Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutes.

Asia-Pacific e-Clinical Solutions Market Regional Analysis/Insights

The Asia-Pacific e-clinical solutions market is analyzed, and market size information is based on product, delivery mode, clinical trial phase, organization size, user device, and end user.

The countries covered in this market report are China, Japan, India, South Korea, Australia, Singapore, Thailand,  Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific.

Japan is expected to dominate the Asia-Pacific region due to the rising adoption of electronic data capture systems and cloud-based solutions.

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了亚太品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战以及销售渠道的影响。

竞争格局和亚太地区电子临床解决方案市场份额分析

亚太地区电子临床解决方案市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、财务状况、产生的收入、市场潜力、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

亚太地区电子临床解决方案市场的一些主要市场参与者包括 Oracle、Signant Health、MaxisIT、Paraxel International Corporation、Dassault Systemes、Clario、Mednet、OpenClinica, LLC、4G Clinical、Veeva Systems、Saama Technologies, LLC、Anju、Castor、Medrio, Inc.、ArisGlobal、Merative、Advarra、eClinical Solutions, LLC、Y-Prime LLC 和 RealTime Software Solutions LLC 等。

SKU-47901